Cargando…

The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy

With the advances in chemotherapy and immunotherapy, a small subset of patients may be eligible for conversion surgery after achieving tumor regression with chemotherapy. This is a retrospective cohort study of 118 patients with stage IV gastric cancer who received palliative chemotherapy and conver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Min-Kyue, Choi, Min-Gew, Kim, Seung-Tae, Kang, Won-Ki, Sohn, Tae-Sung, An, Ji-Yeong, Lee, Joon-Ho, Lee, Jee-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669208/ https://www.ncbi.nlm.nih.gov/pubmed/38002099 http://dx.doi.org/10.3390/biomedicines11113097

Ejemplares similares

Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses
por: Park, Jun Su, et al.
Publicado: (2020)

Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial
por: Kim, Youjin, et al.
Publicado: (2018)

Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
por: Beom, Seung-Hoon, et al.
Publicado: (2018)

Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer()
por: Kim, Seung Tae, et al.
Publicado: (2015)

Long-term oncological outcomes of laparoscopic gastrectomy for grossly early gastric cancer-mimicking advanced gastric cancer: Propensity score matching analysis
por: Oh, Sung Eun, et al.
Publicado: (2020)

The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy
por: Yeom, Seung-Seop, et al.
Publicado: (2020)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability
por: Cho, Junhun, et al.
Publicado: (2017)

Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study
por: Oh, Sung E., et al.
Publicado: (2021)

Prognostic significance of splenectomy during completion total gastrectomy in patients with remnant gastric cancer: propensity score matching analysis
por: Back, Seung Hyun, et al.
Publicado: (2021)

Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer
por: Oh, Sung Eun, et al.
Publicado: (2023)

Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols
por: Yu, Jeong Il, et al.
Publicado: (2019)

Radiofrequency Ablation for Hepatic Metastasis from Gastric Adenocarcinoma
por: An, Ji Yeong, et al.
Publicado: (2008)

Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy
por: Watanabe, Hayato, et al.
Publicado: (2021)

Exome Sequencing Identifies Early Gastric Carcinoma as an Early Stage of Advanced Gastric Cancer
por: Kang, Guhyun, et al.
Publicado: (2013)

A comparison of short-term postoperative outcomes including nutritional status between gastrectomy with simultaneous cholecystectomy and gastrectomy only in patients with gastric cancer
por: Kim, You Na, et al.
Publicado: (2019)

Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma
por: Kim, Su Mi, et al.
Publicado: (2018)

Prognostic implication of hepatoduodenal ligament lymph nodes in gastric cancer
por: Oh, Sung Eun, et al.
Publicado: (2017)

The Predictors and Clinical Impact of Positive Resection Margins on Frozen Section in Gastric Cancer Surgery
por: Kim, Se Yeong, et al.
Publicado: (2012)

Risk Factors and Tumor Recurrence in pT1N0M0 Gastric Cancer after Surgical Treatment
por: Choi, Hee Jun, et al.
Publicado: (2016)

Compliance with D2 lymph node dissection in reduced-port totally laparoscopic distal gastrectomy in patients with gastric cancer
por: Oh, Sung Eun, et al.
Publicado: (2021)

Short-Term Outcomes of Intracorporeal Delta-Shaped Gastroduodenostomy Versus Extracorporeal Gastroduodenostomy after Laparoscopic Distal Gastrectomy for Gastric Cancer
por: Kim, You Na, et al.
Publicado: (2019)

Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer
por: Oh, Sung Eun, et al.
Publicado: (2021)

Long-Term Oncological Outcomes of Reduced Three-Port Laparoscopic Gastrectomy for Early-Stage Gastric Carcinoma: a Retrospective Large-Scale Multi-Institutional Study
por: Lee, Han Hong, et al.
Publicado: (2021)

Early gastric cancer arising from heterotopic gastric mucosa in the gastric submucosa
por: Kim, Dae Hoon, et al.
Publicado: (2011)

Oncological safety of use of ultrasonic activated shears in gastric cancer surgery: Long-term results of randomized controlled trial
por: Kim, Su Mi, et al.
Publicado: (2018)

Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
por: Yu, Jeong Il, et al.
Publicado: (2020)

Comprehensive pharmacogenomic characterization of gastric cancer
por: Sa, Jason K., et al.
Publicado: (2020)

The long-term survival of stage IV gastric cancer patients with conversion therapy
por: Yamaguchi, Kazuya, et al.
Publicado: (2017)

Conversion surgery for stage IV gastric cancer: a multicenter retrospective study
por: Kano, Yosuke, et al.
Publicado: (2022)

Multiple Primary Malignancies in Patients with Multiple Early Gastric Cancer
por: Kim, Dae Hoon, et al.
Publicado: (2017)

Should an Aberrant Left Hepatic Artery Arising from the Left Gastric Artery Be Preserved during Laparoscopic Gastrectomy for Early Gastric Cancer Treatment?
por: Kim, Jieun, et al.
Publicado: (2016)

Deep Learning–Based Survival Analysis Identified Associations Between Molecular Subtype and Optimal Adjuvant Treatment of Patients With Gastric Cancer
por: Lee, Jeeyun, et al.
Publicado: (2018)

Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan
por: Kim, Seung Tae, et al.
Publicado: (2015)

Adenocarcinoma derived from gastric hamartomatous polyps
por: Oh, Seung Jong, et al.
Publicado: (2011)

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies
por: Lee, Min Jeong, et al.
Publicado: (2012)

Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report
por: Fukuda, Kosuke, et al.
Publicado: (2022)

Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy
por: Wang, Chao-Yang, et al.
Publicado: (2020)

Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification
por: Yoshida, Kazuhiro, et al.
Publicado: (2015)

PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
por: Liang, Han
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8bpq1i5e109fdbs6rs70j4lmtc